| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Xenon Pharmaceuticals Inc. | Director | Common Shares | 6,000 | $59,100 | $9.85 | 01 Jun 2023 | Direct |
| Xenon Pharmaceuticals Inc. | Director | Stock Option (Right to Buy) | 18,475 | 02 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 02 Jun 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 17:21 |
| XENE | Xenon Pharmaceuticals Inc. | 30 May 2023 | 19 | -$5,047,797 | 4 | Director | 01 Jun 2023, 19:25 |
| XENE | Xenon Pharmaceuticals Inc. | 07 Mar 2023 | 8 | -$661,251 | 4 | Director | 09 Mar 2023, 17:21 |
| XENE | Xenon Pharmaceuticals Inc. | 12 Aug 2022 | 6 | -$6,775,149 | 4 | Director | 16 Aug 2022, 17:31 |
| XENE | Xenon Pharmaceuticals Inc. | 28 Jun 2022 | 1 | $0 | 4 | Director | 29 Jun 2022, 17:48 |
| XENE | Xenon Pharmaceuticals Inc. | 10 Mar 2022 | 1 | $0 | 4 | Executive Chair, Director | 14 Mar 2022, 16:20 |
| XENE | Xenon Pharmaceuticals Inc. | 04 Mar 2022 | 1 | -$77,000 | 4/A | Director | 08 Mar 2022, 20:41 |
| XENE | Xenon Pharmaceuticals Inc. | 15 Nov 2021 | 1 | -$550,061 | 4 | Director | 16 Nov 2021, 19:40 |
| XENE | Xenon Pharmaceuticals Inc. | 24 May 2021 | 3 | -$12,207 | 4 | CEO, Director | 26 May 2021, 16:11 |